1. Introdution {#s0005}
==============

The term cerebral microbleeds refers to small, round, hypointense lesions on gradient-recalled echo (GRE) or T2\*-weighted magnetic resonance imaging (MRI)([@bb0040]). They are frequently detected in normal elderly population and their presence is associated with an increased risk of intracerebral hemorrhage, ischemic stroke and cognitive impairment([@bb0100]; [@bb0105]). However, the pathogenesis of microbleeds is so far unclear.

Previous histopathologic findings mainly focused on arteries and capillaries, as they have revealed that microbleeds were tiny foci containing hemosiderin-laden macrophages and abnormal microvessels presenting arteriosclerosis, lipohyalinosis, amyloidosis and microaneurysm([@bb0020]), while veins were rarely mentioned. Recently, emerging literatures have demonstrated that venous collagenosis played an important role in the development of cerebral small vessel disease (cSVD)([@bb0075]) and was related to both white matter hyperintensities (WMHs) and lacunar infarcts([@bb0065]). As microbleeds are also an important imaging biomarker of cSVD, it is rational to assume that venous disruption may be involved in the pathogenesis of microbleeds. Interestingly, one recent study in traumatic brain hemorrhage revealed that congestion of the proximal medullary vein might account for the development of microbleeds([@bb0055]). Nevertheless, no other studies have investigated the relationship between venous disruption and microbleeds, yet.

In order to evaluate the extent of venous disruption in vivo, we established a visual deep medullary veins (DMVs) scoring system on susceptibility weighted imaging (SWI) in our previous study. We found an independent association between DMVs score and WMHs volume, especially PVH([@bb0120])s volume, indicating that DMVs might be involved in the pathogenesis of WMHs. In this study, we would continue to use the DMVs scoring system and explore the relationship between microbleeds and DMVs disruption.

It is worthwhile to emphasize that different distributions of microbleeds may suggest different pathological changes and mechanisms. Microbleeds in deep or infratentorial regions are often associated with risk factors for hypertensive vasculopathy, whereas lobar microbleeds, rather, seem indicative of underlying cerebral amyloid angiopathy (CAA)([@bb0090]; [@bb0105]). Therefore, in this study, we also analyzed DMVs disruption according to the distribution of microbleeds and investigated whether the role of venous insufficiency was different in the pathogenesis of microbleeds within different regions.

2. Materials and methods {#s0010}
========================

2.1. Study subjects {#s0015}
-------------------

We retrospectively reviewed the patients admitted to our department who received brain MRI and presented with CSVD imaging markers between January 2010 and December 2017. We retrieved patients\' demographic, clinical, laboratory and imaging data. Inclusion criteria were: (1) cSVD imaging markers (WMHs, lacunas, microbleeds) visible on MRI; (2) age \> 30; (3) had written informed consent. Exclusion criteria were: (1) patients with secondary causes of white matter lesions, such as demyelinating, metabolic, immunological, toxic, infectious, and other causes; (2) patients with abnormal brain MRI findings such as head trauma, hemorrhage, infarction (except lacunas) and other space-occupying lesions; (3) patients with definitive peripheral neuropathy, spinal cord disease; (4) evidence of calcification on CT scans or encephalomalacia in the deep gray matter structures since it may influence the observation of DMVs.

2.2. MRI protocol {#s0020}
-----------------

All subjects underwent multi-model MRI by a 3.0 T MR (MR750, GE Healthcare, United States) scanner using an 8-channel brain phased array coil, including T1, T2 Fluid attenuated inversion recovery (FLAIR), diffusion weighted imaging (DWI) and SWI sequence. In order to minimize head motion, foam pads were inserted into the space between the subject\'s head and the MRI head coil. Axial T2 FLAIR sequence was used to evaluate the WMHs severity with the following parameters: repetition time = 8400 ms, echo time = 150 ms, FOV = 24 cm × 24 cm, matrix size = 256 × 256, inversion time = 2100 ms, slice thickness = 4.0 mm with no gap (continuous) between slices, and in-plane spatial resolution of 0.4688 mm/pixel×0.4688 mm/pixel. The whole brain was imaged. The SWI sequence was in an axial orientation parallel to the anterior commissure to posterior commissure line and covered the whole lateral ventricles, using a three-dimension multi-echo gradient-echo sequence with 11 equally spaced echoes: echo time = 4.5 ms \[first echo\], inter-echo spacing = 4.5 ms, repetition time = 34 ms, FOV = 24 cm × 24 cm, matrix size = 416 × 384, flip angle = 20°, slice thickness = 2.0 mm with no gap between slices and in-plane spatial resolution of 0.4688 mm/pixel. Flow compensation was applied. Magnitude and phase images were acquired. Other sequences included 3D-T1 (TR = 7.3 ms, TE = 3.0 ms, flip angle 15°, slice thickness 1 mm, matrix size = 250 × 250, FOV = 25 cm) and DWI (TR = 4000 ms, TE = 69.3 ms; b-value = 1000 s/mm2, three slabs, slice thickness 5.0 mm; interslice gap P = 1.0 mm, spatial resolution of 0.9375 × 0.9375 mm/pixel, FOV = 24 × 24 cm^2^, matrix size = 160 × 160).

2.3. Measurement of DMVs {#s0025}
------------------------

The raw data were transferred to a separate workstation (ADW4.4, GE), and we used a custom built program to reconstruct the magnitude and phase images.

DMVs were assessed on SWI phase images. Five consecutive periventricular slices (10 mm thick) from the level of the ventricles immediately above the basal ganglia to the level of the ventricles immediately disappeared were analyzed. Six regions including frontal region, parietal region and occipital region (bilateral, respectively) were separated on the above five slices according to medullary venous anatomy, and the characteristics of the DMVs were then evaluated in each region, respectively([@bb0120]).

As described in our previous study, we used the four-point score to evaluate DWVs([@bb0120]): Grade 0 - each vein was continuous and had homogeneous signal; Grade 1- each vein was continuous, but one or more than one vein had inhomogeneous signal; Grade 2 - one or more than one vein was not continuous, presented with spot-like hypointensity; Grade 3 - No observed vein was continuous. The final DWVs score is the sum of the six regions ranging from 0 to 18. Two neurologists, who were completely blinded to the subjects\' clinical data and disease state, visually assessed the vascular changes.

2.4. Measurement of WMHs {#s0030}
------------------------

T2 FLAIR sequences of brain MRI scans were used to assess WMHs, which were analyzed by two neurologists who were blinded to the clinical data. Disagreements were resolved through consensus. The Fazekas scale([@bb0015]) visual grading scale were used for rating WMHs. According to the Fazekas scale, the WMHs were divided into periventricular hyperintensities (PVHs) and deep white matter hyperintensities (DWMHs). PVHs were graded as absent (grade 0), cap (grade 1), smooth halo (grade 2), or irregular and extending into the subcortical white matter (grade 3), and DWMHs were graded as absent (grade 0), punctate foci (grade 1), early-confluent (grade 2), or confluent (grade 3). The final white matter lesion severity is the sum of the two regions ranging from 0 to 6.

2.5. Evaluation of microbleeds {#s0035}
------------------------------

Microbleeds were identified according to a field guide of microbleeds detection and interpretation. Briefly, microbleeds should be small, rounded or circular, well defined hypointense lesions within brain parenchyma with clear margins ranging from 2 to 10 mm in size([@bb0040]).

We described the locations and counted the numbers of microbleeds on SWI magnitude images. Microbleeds were classified as absent (grade 1), mild (grade 2; total number of microbleeds: 1--2) and extensive (grade 3; total number of microbleeds≥3). Microbleeds were counted in lobar regions (frontal, parietal, temporal, and occipital); and in deep (basal ganglia and thalamus, corpus callosum) or infratentorial(brain stem and cerebellum) regions. Patients with≥1 microbleeds only restricted to lobar regions were considered to have strict lobar microbleeds, and those with microbleeds in a deep or infratentorial region, with or without concomitant lobar microbleeds were considered to have non-strict lobar microbleeds([@bb0010]; [@bb0090]).

2.6. Evaluation of lacunas {#s0040}
--------------------------

T2 FLAIR images were used to identify lacunas, which were defined as cavities with signal intensities similar to cerebrospinal fluid on MRI and with a diameter of 3 to 10 mm which was different from the enlarged Virchow--Robin spaces by the size, shape, and rim([@bb0035]).

2.7. Statistical analysis {#s0045}
-------------------------

Fisher\'s exact test was used to compare the categorical data between groups. A one-way analysis of variance or Kruskal-Wallis test was used between multiple groups. Variables with a p \< 0.1 in univariate regression analyses were included in the multinomial logistic regression. All analyses were performed blinded to the participant identifying information. Statistical significance was set at a probability value of \<0.05. All statistical analysis was performed with SPSS package (21st for Windows, IBM).

3. Results {#s0050}
==========

3.1. Subject characteristics {#s0055}
----------------------------

Totally, 369 patients were enrolled in this study (163 female; mean age, 66.2 ± 11.0 years). The main reasons for admission of those patients were transient ischemic attack (TIA) or lacunar ischemic stroke (n = 196, 53.1%), dizziness (n = 68, 18.4%), cognitive impairment (n = 25, 6.8%), gait disturbance (n = 14, 3.8%), anxiety or depression (n = 14, 3.8%), no specific symptoms but were found to have WMH (Fasekas score \> 0) on MRI (n = 74, 20.1%). Besides, among 369 patients, 268 (from January 2010 to April 2016) had been enrolled in our previous study which demonstrated that WMH was associated with DMVs disruption. We reinvestigated the relationship between DMVs and WMH in the newly collected 101 patients (from May 2016 to December 2017), and we found that DMVs score was significantly correlated with WMH Fazekas score (Spearman *r* = 0.580, p \< 0.001).

3.2. Frequency and location of baseline microbleeds {#s0060}
---------------------------------------------------

Of the included patients, 177 (48.0%) subjects presented with microbleeds. Among patients with microbleeds, 81 (45.8%) patients had 1--2 microbleeds (mild microbleeds), and 96 (54.2%) patients had ≥3 microbleeds (extensive microbleeds). 38 (21.5%) patients had strict lobar microbleeds, while 139 (78.5%) patients had non-strict lobar microbleeds. The detailed distribution of microbleeds can be seen in [Fig. 1](#f0005){ref-type="fig"}.Fig. 1Distribution of microbleeds in our study.Fig. 1

3.3. Univariate and multivariate regression analysis of microbleeds severity {#s0065}
----------------------------------------------------------------------------

We classified the patients into absent, mild and extensive microbleeds groups. [Table 1](#t0005){ref-type="table"} shows the characteristics of patients for comparison. Patients with extensive microbleeds had a higher proportion of male (66.7% vs 49.5%, p = 0.018) and higher frequency of hyperhomocysteinemia (27.1% vs 11.5%, p = 0.003) compared with those without microbleeds. Patients with extensive microbleeds had higher Fazekas scores (5 (4--6) vs 4 (3--5) vs 4 (3--5), p \< 0.001, p \< 0.001), higher DMVs scores (5 (4--6) vs 4 (3--5) vs 4 (3--5), p \< 0.001, p \< 0.001), and more lacunas (2 (1--5) vs 0 (0--2) vs 0 (0--1), p \< 0.001, p \< 0.001) than those with mild microbleeds or without microbleeds.Table 1Univariate comparison of characteristics among patients with microbleeds of different severity.Table 1Absent microbleeds (n = 192)Mild microbleeds (n = 81)Extensive microbleeds (n = 96)P valueAge (Y)66.06 ± 11.2066.91 ± 10.8365.93 ± 10.830.808Female97 (50.5)34 (42)32 (33.3)0.019Past medical historyHypertension126 (65.6)59 (72.8)75 (78.1)0.079Diabetes mellitus36 (18.8)16 (19.8)28 (29.2)0.139Hyperlipidemia44 (22.9)24 (29.6)17 (17.7)0.187Hyperhomocysteinemia22 (11.5)13 (16.0)26 (27.1)0.004  Clinical variablesSBP (mmHg)146.69 ± 22.67148.06 ± 19.92153.52 ± 21.890.048DBP (mmHg)82.42 ± 12.7083.41 ± 11.9487.53 ± 12.740.006Platelet (10^9^/L)186.97 ± 58.32201.01 ± 70.86184.25 ± 68.020.186APTT (s)34.02 ± 10.7333.81 ± 14.0031.41 ± 8.630.218INR1.00 ± 0.190.96 ± 0.270.98 ± 0.260.597Glucose (mmol/L)5.99 ± 2.085.98 ± 2.175.97 ± 2.230.999TC (mmol/L)4.41 ± 1.114.35 ± 1.194.25 ± 1.100.555Hcy (μmol/L)13.37 ± 6.5414.60 ± 8.3515.42 ± 7.030.060Hs-CRP (mg/L)4.81 ± 7.287.56 ± 14.225.84 ± 7.790.141  Radiology dataFazekas score4 (3--5)4 (3--5)5 (4--6)\<0.001DMVs score8 (6--10)8 (6--11)12 (8--16)\<0.001Number of lacunas0 (0--1)0 (0--2)2 (1--5)\<0.001[^2]

[Table 2](#t0010){ref-type="table"} shows the results of the multivariate analysis. High DMVs score was independently associated with the presence of extensive microbleeds (OR = 1.108, 95% Cl: 1.010--1.215, p = 0.03) after adjusting for gender, hypertension, hyperhomocysteinemia, Fazekas score and number of lacunas.Table 2Multinomial logistic regression analysis for microbleeds of different severity.Table 2OR95%ClP valueMild microbleeds (compared with absent microbleeds)Female0.6750.385--1.1830.169Hypertension1.4800.808--2.7130.204Hyperhomocysteinemia1.2400.565--2.7210.592DMVs score1.0800.987--1.1810.093Number of lacunas1.1871.023--1.3760.023Fazekas score1.0590.845--1.3280.618  Extensive microbleeds (compared with absent microbleeds)Female0.4030.216--0.7500.004Hypertension2.6211.273--5.5950.009Hyperhomocysteinemia1.7980.852--3.7930.123DMVs score1.1081.010--1.2150.030Number of lacunas1.2831.113--1.4790.001Fazekas score1.6861.275--2.230\<0.001[^3]

3.4. Univariate and multivariate regression analysis of microbleeds location {#s0070}
----------------------------------------------------------------------------

We classified the patients into absent microbleeds, strict lobar microbleeds and non-strict lobar microbleeds groups according to the distribution of microbleeds. [Table 3](#t0015){ref-type="table"} shows the characteristics of patients for comparison. Patients with non-strict lobar microbleeds had a higher proportion of male (64.0% vs 49.5%, p = 0.003), higher frequency of hyperhomocysteinemia (21.1% vs 11.5%, p = 0.003), higher Fazekas scores (5 (4--6) vs 4 (3--5), p \< 0.001), higher DMVs scores (10 (8--16) vs 8 (6--10), p \< 0.001), and more lacunas (2 (0--4) vs 0(0--1), p \< 0.001) than those absent of microbleeds.Table 3Univariate comparison of characteristics among patients with microbleeds of different distribution.Table 3Absent microbleeds (n = 192)Non-strict lobar microbleeds (n = 139)Strict lobar microbleeds (n = 38)P valueAge (Y)66.06 ± 11.2065.61 ± 11.0869.18 ± 9.330.200Female97 (50.5)50 (36.0)16 (42.1)0.031Past medical historyHypertension126 (65.6)107 (77.0)27 (71.1)0.080Diabetes mellitus36 (18.8)38 (27.3)6 (15.8)0.140Hyperlipidemia44 (22.9)30 (21.6)11 (28.9)0.589Hyperhomocysteinemia22 (11.5)31 (22.3)8 (21.1)0.021  Clinical variablesSBP (mmHg)146.69 ± 22.67151.72 ± 22.42148.50 ± 15.730.130DBP (mmHg)82.42 ± 12.7085.90 ± 12.8184.74 ± 15.520.049Platelet (10^9^/L)186.97 ± 58.32194.46 ± 64.43183.29 ± 85.510.495APTT (s)34.02 ± 10.7332.10 ± 8.6333.56 ± 17.730.396INR1.00 ± 0.190.97 ± 0.230.98 ± 0.380.593Glucose (mmol/L)5.99 ± 2.085.99 ± 2.405.93 ± 2.300.989TC (mmol/L)4.41 ± 1.114.20 ± 1.124.61 ± 1.150.110Hcy (μmol/L)13.38 ± 6.5414.85 ± 6.5315.82 ± 10.880.062Hs-CRP (mg/L)4.81 ± 7.286.19 ± 10.787.88 ± 11.710.171  Radiology dataFazekas score4 (3--5)5 (4--6)4 (4--5)\<0.001DMVs score8 (6--10)10 (8--16)8 (6--12)\<0.001Number of lacunas0 (0--1)2 (0--4)0 (0--1)\<0.001[^4]

[Table 4](#t0020){ref-type="table"} shows the results of the multivariate analysis. High DMVs score was independently associated with the presence of non-strict lobar microbleeds (OR = 1.106, 95% Cl: 1.019--1.200, p = 0.016) after adjusting for gender, hypertension, hyperhomocysteinemia, Fazekas score and number of lacunas. DMVs score was not associated with strict lobar microbleeds. [Fig. 2](#f0010){ref-type="fig"} consisted representative images indicating the correlation between deep medullary veins (DMVs) and microbleeds with different distribution.Table 4Multinomial logistic regression analysis for microbleeds of different distribution.Table 4OR95%ClP valueNon-strict lobar microbleeds (compared with absent microbleeds)Female0.4950.291--0.8410.009Hypertension2.2211.213--4.0660.010Hyperhomocysteinemia1.4660.733--2.9310.280DMVs score1.1061.019--1.2000.016Number of lacunas1.2761.112--1.4650.001Fazekas score1.3311.069--1.6570.011  Strict lobar microbleeds (compared with absent microbleeds)Female0.6790.325--1.4200.304Hypertension1.2220.561--2.6620.613Hyperhomocysteinemia1.7080.666--4.3800.266DMVs score1.0630.945--1.1950.307Number of lacunas1.0870.888--1.3300.421Fazekas score1.1330.841--1.5250.411[^5]Fig. 2Representative images indicating the correlation between deep medullary veins (DMVs) and microbleeds with different distribution. Susceptibility weighted imaging (SWI) magnitude image shows microbleeds distributed in different regions (A-C) and phase image shows venous disruption reflected with DMVs score (D-F). The left column (A and D) shows a patient with no microbleeds and a DMVs score of 6. The middle column (B and E) shows a patient with non-strict lobar microbleeds and a DMVs score of 16. The right column (C and F) shows a patient with strict lobar microbleeds and a DMVs score of 8.Fig. 2

4. Discussion {#s0075}
=============

In the current study, we found that patients with extensive microbleeds had higher DMVs scores than those without microbleeds. Also, we demonstrated that high DMVs score was associated with non-strict lobar microbleeds rather than strict lobar microbleeds, which suggested that venous disruption may be involved in the pathogenesis of non-strict lobar microbleeds. It should be noted that, in our study, the effect of DMVs on microbleeds was independent of conventional vascular risk factors such as hypertension, diabetes and hyperhomocysteinemia, though it was taken for granted that these factors could be responsible for the changes of venous disruption.

Venous insufficiency could increase static pulse pressure, result in peripheral interstitial edema and decrease venous oxygenation in the drainage area, finally ending in BBB disruption([@bb0065]; [@bb0070]), while BBB disruption has been demonstrated to be related with microbleeds both in patients and animal models([@bb0025]; [@bb0080]). Actually, the disruption of BBB has been considered as the core mechanism underlying cSVD([@bb0095]). Therefore, it is rational to assume that the effects of DMVs on the pathogenesis of cSVD may be mediated by BBB disruption. Future studies are still needed to validate it.

Interestingly, we found that venous disruption, reflected by high DMVs score was related to the presence of non-strict lobar microbleeds, instead of strict lobar microbleeds. Strict lobar microbleeds were mainly related to cerebral amyloid angiopathy (CAA) according to the current theory, while non-strict lobar microbleeds were considered to be related with hypertension([@bb0090]). Amyloid-β is deposited in perivascular interstitial fluid drainage pathways of the brain and contributes significantly to cerebral amyloid angiopathy. Pathological and immunochemical studies of CAA indicated that amyloid-β accumulated more frequently around cortical vessels, but less frequently seen in the basal ganglia, thalamus, cerebellum, white matter and brainstem([@bb0005]). Therefore, DMVs, which localized in deep white matter were less involved in CAA-related pathological changes. Besides, our present study only focused on DMVs, but didn\'t investigate superficial medullary veins and cortical veins, so further studies focusing on the interaction between veins and strict lobar microbleeds are needed. On the other side, previous animal study found that venous collagenosis was also associated with hypertension([@bb0125]). Venous wall thickness is increased by blood pressure elevation, in order to restore circumferential wall stress to a normal level([@bb0045]). To summarize, our results further indicated that DMVs disruption is associated with hypertension instead of CAA.

In addition, previous studies showed that the number of microbleeds could reflect the severity of SVD([@bb0110]; [@bb0115]). Extensive microbleeds were related to structural network disruption in patients with impaired cognition, and were also associated with parenchymal hemorrhage and poor outcome after intravenous thrombolysis in patients with acute ischemia stroke([@bb0050]). Therefore, considering the connection between higher DMVs scores and extensive microbleeds, DMVs scores might also be a clinically significant marker for cSVD.

Besides, we found that extensive microbleeds were more frequent in male patients and patients with hypertension, which is consistent with Framingham Study and AGES-Reykjavik study([@bb0060]; [@bb0085]). In addition, we also found that microbleeds, especially non-strict lobar microbleeds were closely related to WMHs and lacunas, which is also in line with previous studies([@bb0030]).

Our study had limitations. First, it was a cross-sectional study. Causality of the conclusions above is difficult to prove, and follow-up studies are required to clarify the correlation between DMVs scores and the risk of microbleeds. Second, this study only included Chinese patients who were admitted to department of neurology of our hospital due to distinct imaging changes or symptoms, especially 53.1% patients were diagnosed with TIA/lacunar ischemic stroke. Therefore, it may not represent the full spectrum of cSVD and selection bias existed. Future prospective studies in larger and multicenter cohorts are required to clarify our results. Third, DMVs participate in the direct drainage of surrounding white matter, but they are not directly associated with deep microbleeds located in basal ganglia and thalamus, or infratentorial microbleeds located in brain stem and cerebellum. Therefore, we speculate that the influence of DMVs on non-strict lobar microbleeds was probably indirect, which meant that DMVs disruption reflected the insufficiency of intracranial venous bed. However, since comprehensive assessment of small intracranial veins is not yet established, our hypothesis still needs further investigation.

In summary, DMVs disruption was associated with microbleeds, especially non-strict lobar microbleeds and extensive microbleeds, indicating that venous insufficiency may be one of the pathogenic mechanisms of microbleeds. Our results may provide insights in novel therapies for microbleeds targeting cerebral venous drainage.
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